Title of article
Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors
Author/Authors
Jens-Erik Jorgensen، نويسنده , , Henning Kelb?k، نويسنده , , Steffen Helqvist، نويسنده , , Gunnar V. H. Jensen، نويسنده , , Kari Saunam?ki، نويسنده , , Jens Kastrup، نويسنده , , Ole Havndrup، نويسنده , , Henning Bundgaard، نويسنده , , Jan Kyst Madsen، نويسنده , , Michael Christiansen، نويسنده , , Paal S. Andersen، نويسنده , , Johan H. C. Reiber، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2001
Pages
6
From page
1434
To page
1439
Abstract
OBJECTIVES
This study aimed to clarify the role of the angiotensin-converting enzyme (ACE) gene polymorphism in the development of in-stent restenosis.
BACKGROUND
In-stent restenosis occurs after treatment of coronary artery stenosis in 12% to 32% of coronary interventions with stents. Experimental and clinical studies have suggested that the deletion/insertion (D/I) polymorphism of the ACE gene plays a role in this.
METHODS
Quantitative coronary angiography before, immediately after and six months after stent implantation were compared in 369 patients, in whom D/I typing of the ACE gene was performed.
RESULTS
At follow-up we found no differences between the three genotypes in minimal lumen diameter (homozygotes with two deletion alleles in the ACE gene [DD], 2.20 mm; heterozygotes with one deletion and one insertion allele in the ACE gene [DI], 2.19 mm; and homozygotes with two insertion alleles in the ACE gene [II], 2.25 mm). The corresponding diameter stenoses were: DD: 25%, DI: 27%, II: 27% (p = NS), and the frequency of restenosis (>50% diameter stenosis) was: DD: 15.7%, DI: 11.0% and II: 16.4% (p = NS). Logistic regression analysis identified diabetes (odds ratio [OR]: 3.0, 95% confidence interval [CI]: 1.0 to 8.7), lesion length (OR: 1.1, 95% CI: 1.01 to 1.30) and minimal lumen diameter immediately after the intervention (OR: 0.3, 95% CI: 0.14 to 0.85) as predictors of in-stent restenosis. In a post hoc analysis of patients treated versus those not treated with an ACE-inhibitor antagonist or an angiotensin receptor antagonist, we found an increased frequency of in-stent restenosis in the DD genotypes (40% vs. 12%, P = 0.006).
CONCLUSIONS
The D/I polymorphism is not an independent predictor of coronary in-stent restenosis in general, but it may be of clinical importance in patients treated with ACE inhibitors or angiotensin receptor antagonists.
Keywords
D/I , deletion/insertion , Di , Ii , homozygotes with two insertion alleles in the ACE gene , PTCA , percutaneous transluminal coronary angioplasty , QCA , quantitative coronary angiography , angiotensin-converting enzyme , ACE , DANSTENT , Danish Randomized Multicenter Trial of Coronary Restenosis After Treatment with the NIR and the Palmaz-Schatz Stent , homozygotes with two deletion alleles in the ACE gene , DD , heterozygotes with one deletion and one insertion allele in the ACE gene
Journal title
JACC (Journal of the American College of Cardiology)
Serial Year
2001
Journal title
JACC (Journal of the American College of Cardiology)
Record number
596891
Link To Document